Embody vs Enhance MD: Which GLP-1 Provider Is Better?
A side-by-side comparison of Embody and Enhance MD covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#21 of 31Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit EmbodyEnhance MD
#8 of 31Affordable telehealth provider offering both compounded and brand-name GLP-1 medications with combination therapy options.
Visit Enhance MD| Feature | Embody | Enhance MD |
|---|---|---|
| Our Score | 7.8/10 | 8.3/10 |
| Starting Price | $149/mo | $115/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Budget-conscious users interested in combination therapies |
| Ranking | #21 | #8 |
Pros & Cons Compared
Embody
Pros
- +24/7 specialist support
- +Competitive pricing
- +Good for beginners
- +Responsive team
Cons
- −Compounded only
- −No insurance
Enhance MD
Pros
- +$115/mo starting price with access to both brand-name and compounded — rare at this price point
- +Offers combination therapies (GLP-1 + B12, GLP-1 + NAD+) for patients wanting enhanced protocols
- +Quick asynchronous consultations — most patients approved within 24 hours without video calls
- +Flexible dosing: can start at lower doses than standard protocols for sensitive patients
Cons
- −Lighter clinical support than higher-priced platforms — check-ins are patient-initiated, not scheduled
- −No insurance billing and limited customer support hours (business days only, no weekends)
Our Verdict
Enhance MD edges out Embody with a score of 8.3/10 vs 7.8/10. If budget is your priority, Enhance MD starts at $115/mo compared to Embody's $149/mo. Enhance MD offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Enhance MD if you want: budget-conscious users interested in combination therapies.